Postvaccinal Reactions and Complications
1966; Wiley; Volume: 180; Issue: S464 Linguagem: Inglês
10.1111/j.0954-6820.1966.tb05076.x
ISSN0001-6101
AutoresElias Bengtsson, Sven Ove Hansson, Bertil Nyström,
Tópico(s)Venous Thromboembolism Diagnosis and Management
ResumoActa Medica ScandinavicaVolume 180, Issue S464 p. 89-104 Postvaccinal Reactions and Complications Elias Bengtsson, Elias Bengtsson Hospital for Infectious Diseases, StockholmSearch for more papers by this authorSven Hansson, Sven Hansson Hospital for Infectious Diseases, StockholmSearch for more papers by this authorBertil Nyström, Bertil Nyström Hospital for Infectious Diseases, StockholmSearch for more papers by this author Elias Bengtsson, Elias Bengtsson Hospital for Infectious Diseases, StockholmSearch for more papers by this authorSven Hansson, Sven Hansson Hospital for Infectious Diseases, StockholmSearch for more papers by this authorBertil Nyström, Bertil Nyström Hospital for Infectious Diseases, StockholmSearch for more papers by this author First published: January/December 1966 https://doi.org/10.1111/j.0954-6820.1966.tb05076.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Barandren, S., Huser, H.J. & Hassig, A.: Klinische Erscheinungsformen des Anti-körpermangelsyndroms. Schweiz med. Wchnschr. 88: 78, 1958. Google Scholar 2 Barbero, G. J.: Discussion. Amer. J. Dis. Child. 88: 396, 1954. Web of Science®Google Scholar 3 Barlow, A. J. E.: Drug for vaccinia. Brit. Med. J. no. 5285, p. 1144, 1962. 10.1136/bmj.1.5285.1144-a Web of Science®Google Scholar 4 Bauer, D. J. & Sadler, P. W.: New antiviral chemotherapeutic agent active against smallpox infection. Lancet no. 7224, p. 330, 1962. PubMedWeb of Science®Google Scholar 5 Bauer, D. J., Vincent, L. S., Kempe, C. H. & Downing, A. W.: Prophylactic treatment of smallpox contacts with N-metylisatin-beta-thiosemicarbazone (33T53). (Lancet no. 7306, p. 494, p. 501, 1963. 10.1016/S0140-6736(63)90230-7 CASPubMedWeb of Science®Google Scholar 6 Bengtsson, E., Holmgren, A. & Nyström, B.: Circulatory Studies in Patients with Abnormal ECG in the Course of Postvaccinal Complications. Acta Med. Scand. Suppl. 464, 113, 1966. CASGoogle Scholar 7 Cochran, W., Connolly, J. H. & Thompson, I. D.: Bone involvement after vaccination against smallpox. Brit. Med. J. no. 5352, p. 285, 1963. 10.1136/bmj.2.5352.285 CASGoogle Scholar 8 Dewar, W. A. & Finn, O. A.: Vaccination in the presence of skin disease. Glasgow Med. J. 95: 141, 1954. Google Scholar 9 Dixon, C. W.: Smallpox. Churchill, London 1962. Google Scholar 10 Doloopol, V. B., Greenberg, M. & Aronoff, R.: Encephalitis following smallpox vaccination. Arch. Neurol. & Psychiatr. 73: 216, 1955. 10.1001/archneurpsyc.1955.02330080094018 Google Scholar 11 Doly, J. J. & Jackson, E.: Vaccina gangrenosa treated with N-metylisatin-beta-thiosemicarbazone. Brit. Med. J. no. 5315, p. 1300, 1962. 10.1136/bmj.2.5315.1300 CASGoogle Scholar 12 Ehrengut, W.: Uber Persistenz des Vaccine-Virus nach der Pockenschutzimpfung. Zugleich ein Beitrag zur Frage der vaccina-len Immunitat. Ztschr. f. Hygiene. 148: 230, 1962. 10.1007/BF02161376 CASPubMedWeb of Science®Google Scholar 13 Ehrengut, W. & Fehringer, W. D.: Persistenz des Vakzinevirus in Impfulzera. Dtsch. Med. Wchnschr. 8: 365, 1963. 10.1055/s-0028-1111956 Google Scholar 14 Eliott, W. D.: Vaccinal osteomyelitis. Lancet 2: 1053, 1952. PubMedGoogle Scholar 15 Espmark, Å.: Vaccin och vaccination mot smittkoppor. Sv. läkartidn. 55: 2745, 1958. CASPubMedGoogle Scholar 16 Espmark, Å.: Production and use of egg vaccine. Compte-rendus du symposium sur la vaccination antivariologie. Lyon 6/9 Dc. 1962. Google Scholar 17 Espmark, Å., Biberfeld, G., Fagraeus, A., Johnsson, T., Jonsson, J. & Magnusson, B.: Virological Findings during the smallpox outbreak in Stockholm in 1963. Acta Med. Scand. Suppl. 464, 71, 1966. CASPubMedWeb of Science®Google Scholar 18 Espmark, Å.: Smallpox vaccination with serial dilutions of vaccinia. IV. Graded local responses and fever reactions following primary vaccination in children. To be published in Acta Paediatr. Google Scholar 19 Flick, J. A. & Pincus, W. B.: Inhibition of the lesions of primary vaccinia and of delayed hypersensitivity through immunological tolerance in rabbits. J. Exp. Med. 117: 633, 1963. 10.1084/jem.117.4.633 CASPubMedWeb of Science®Google Scholar 20 Frank, L.: Complications of vaccination. J. Cut. & Genito-Urinary Dis. 13: 142, 1895. Google Scholar 21 Freud, P., Maffie, A. J., Hosbach, R. E. & Valicanti, P. W.: Smallpox vaccination followed by acute renal failure. J. Dis. Childr. 99: 98, 1960. CASPubMedWeb of Science®Google Scholar 22 Friedman, R. M. & Baron, S.: The role of antibody in recovery from infection with vaccinia virus. J. Immunol. 87: 379, 1961. CASPubMedWeb of Science®Google Scholar 23 Friihaufowa, J.: Post-vaccinal complications in Poland during the years 1958 and 1959. Pediat. Pol. 36/10: 1047, 1961. Google Scholar 24 Ref. Excerpt. Med., Med. Microbiol. Imm. & Serol. 15: 493, 1962. Google Scholar 24 Grendahl, H.: Koppevaksinasjon og ek-sem. Tidskr. Norsk Lægeforen. 83: 889, 1963. CASPubMedGoogle Scholar 25 Gins, H. A.: Zbl. ges. Kinderheilk. 24: 148, 1930. Ref. from Ehrengut & Fehringer (13). Google Scholar 26 Hargreaves, E. R.: Risks of smallpox vaccination. Brit. Med. J. no. 5320, p. 1685, 1962. 10.1136/bmj.2.5320.1685 CASWeb of Science®Google Scholar 27 Hallman, N., Hjelt, L. & Wegelius, R.: Hypergammaglobulinemia in infants. Ann. paed. Fenn. 2: 272, 1956. CASPubMedGoogle Scholar 28 Hansson, O. & Vahlqvist, B.: Vaccinia gangrenosa and compound 33T57. Lancet no. 7309, 1963. Google Scholar 29 Havles, A. B., Stickler, G. B. & Mc-Kenzie, B. F.: Decrease in serum globulin (agammaglobulinaemia); report in 3 cases. Pediatrics 14: 444, 1954. Google Scholar 30 Herbut, P. A.: Diffuse glomerulonephritis following revaccination for smallpox. Am. J. Pathol. 20: 1611, 1944. Google Scholar 31 Holmgren, B. & Lindblom, U.: Neurological Complications after Smallpox Vacccination. Acta Med. Scand. Suppl. 464, 105, 1966. CASGoogle Scholar 32 Hutchinson, J. H.: Congenital agammaglobulinemia. Lancet p. 844, 1957. Google Scholar 33 Kempe, C. H., Berge, T. O. & Englant, B.: Pediatrics 18: 177, 1956. 10.1542/peds.18.2.177 CASPubMedWeb of Science®Google Scholar 34 Kempe, H. C.: Studies on smallpox and complications of smallpox vaccination. Pediatrics 26: 176, 1960. CASPubMedWeb of Science®Google Scholar 35 Lundström, R.: Complications of smallpox vaccination and their treatment with vaccinia immune gammaglobulin. J. Pediatr. 49: 129, 1956. 10.1016/S0022-3476(56)80028-0 CASPubMedWeb of Science®Google Scholar 36 Lundström, R. & Espmark, Å.: Immune globulin against vaccinia. Acta Paediatr. 48 (Suppl. 118), 88, 1959. 10.1111/j.1651-2227.1959.tb17510.x Google Scholar 37 Lukács, F. V., Rosta, J. & Szathmáry, J.: Über die erusthaften Komplikationen der Vakzination. Ann. Paediatr. 191: 307, 1958. PubMedWeb of Science®Google Scholar 38 Lyon, E.: The present status of antismall-pox vaccination. Israel. Med. J. 17: 257, 1958. CASPubMedGoogle Scholar 39 Mainland, D.: Elementary medical statistics. W. B. Saunders, Philadelphia 1952. Google Scholar 40 Mayne, N., FitzGerald, M. G. & Houghton, A. C.: Postvaccinal myelitis. Lancet no. 7231, p. 691, 1962. 10.1016/S0140-6736(62)92909-4 Web of Science®Google Scholar 41 Meindersma, T. E. & Uries, S. I.: Thrombocytopenic purpura after smallpox vaccination. Brit. Med. J. no. 5273, p. 226, 1962. 10.1136/bmj.1.5273.226 CASWeb of Science®Google Scholar 42 Mustard, H. S. & Hedrich, P. W.: Generalized vaccinia. J. Pediatr. 33: 281, 1948. 10.1016/S0022-3476(48)80102-2 PubMedWeb of Science®Google Scholar 43 Nanning, W.: Prophylactic effect of anti-vaccinia gamma-globulin, against postvaccinal encephalitis. Bull WHO 27: 317, 1962. CASPubMedWeb of Science®Google Scholar 43a Norén, L., Espmark, Å., Fagraeus, A., Holm, S. E., Lindahl, J., Lycke, E. & Marquardt, J.: Vaccinia antigens for skin testing. Preparations of antigens and quantitative studies of skin reactions in “Standard populations”. Acta Med. Scand. Suppl. 464, 162, 1966. Google Scholar 44 Pincus, W. B. & Flick, J. A.: The role of hypersensitivity in the pathogenesis of vaccinia virus infections in humans. J. Pediatr. 62: 57, 1963. 10.1016/S0022-3476(63)80071-2 CASPubMedWeb of Science®Google Scholar 45 von Pirguet, C.: Klinische Studien über Vakzination und vakzinale Allergie. Franz Quentike, 1907. Google Scholar 46 Rajka, G. & Nilzén, Å.: Postvaccinal Dermatoses. Acta Med Scand. Suppl. 464, 158, 1966. CASGoogle Scholar 47 Kling, C. A. & Ohlin, G.: Statens offentliga utredningar 28: 1937. Socialdepartementet, Stockholm 1937. Betänkande med förslag till lag om skyddskoppympning m. m. Google Scholar 48 The future of smallpox vaccination. Editorial. Lancet no. 7334 p. 649, 1964. Google Scholar 49 Turner, W.: Eczema vaccinatum treated with N-metylisatbetathiosemicarbazone. Brit. Med. J. no. 5288, p. 1317, 1962. Web of Science®Google Scholar 50 Turk, J. L., Allison, A. C. & Oxman, M. N.: Delayed hypersensitivity in relation to vaccination and multiplication of vaccinia virus in the guineapig. Lancet no. 7226, p. 405, 1962. 10.1016/S0140-6736(62)91362-4 CASPubMedWeb of Science®Google Scholar 51 Törnquist, R.: Vacciniakeratit. Nord. Med. 63: 823, 1960. Google Scholar 52 Zetterberg, B., Ringertz, O., Svedmyr, A., Wallmark, G. and Alin, K.: Epidemiology of Smallpox in Stockholm 1963. Acta Med. Scand. Suppl. 464, 7, 1966. CASGoogle Scholar Volume180, IssueS464January/December 1966Pages 89-104 ReferencesRelatedInformation
Referência(s)